Beihai Gofar Chuanshan Biological Co.,Ltd.’s Net Profit Rose 312.5% in First Three Quarters of 2022

Beihai Gofar Chuanshan Biological Co.,Ltd. (北海国发川山生物股份有限公司) (600538.SH) reported a net profit of 34.3 million yuan in the first three quarters of 2022, up 312.5% year-on-year.

Meanwhile, the company posted 338.4 million yuan in revenue, up 11.1% year-on-year.

At the end of the reporting period, it had 1.1 billion yuan in total assets and 156.6 million yuan in total liabilities, with a liability-to-asset ratio of 14.1%.